Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness.
Motion sickness is a common condition experienced by around 50% to 60% of the general global population. It is more common in children and elderly. Various prescription and over the counter (OTC) drugs and products are available for treat motion sickness.
Market Analysis and Insights: Global Motion Sickness Treatment Market
The global Motion Sickness Treatment market size is projected to reach US$ 566.4 million by 2026, from US$ 552.1 million in 2020, at a CAGR of 2.4%% during 2021-2026.
Global Motion Sickness Treatment Scope and Market Size
Motion Sickness Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Motion Sickness Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
GlaxoSmithKline
Perrigo Company
Prestige Brands
WellSpring Pharmaceutical Corporation
Caleb Pharmaceuticals
Myungmoon Pharm
Baxter International
Reliefband Technologies
Motion Sickness Treatment Breakdown Data by Type
Anticholinergic
Antihistamines
Others
Motion Sickness Treatment Breakdown Data by Application
Hospitals
Clinics
Other
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Motion Sickness Treatment Revenue
1.4 Market by Type
1.4.1 Global Motion Sickness Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Anticholinergic
1.4.3 Antihistamines
1.4.4 Others
1.5 Market by Application
1.5.1 Global Motion Sickness Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Motion Sickness Treatment Market Perspective (2015-2026)
2.2 Global Motion Sickness Treatment Growth Trends by Regions
2.2.1 Motion Sickness Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Motion Sickness Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Motion Sickness Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Motion Sickness Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Motion Sickness Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Motion Sickness Treatment Players by Market Size
3.1.1 Global Top Motion Sickness Treatment Players by Revenue (2015-2020)
3.1.2 Global Motion Sickness Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Motion Sickness Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Motion Sickness Treatment Market Concentration Ratio
3.2.1 Global Motion Sickness Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Motion Sickness Treatment Revenue in 2019
3.3 Motion Sickness Treatment Key Players Head office and Area Served
3.4 Key Players Motion Sickness Treatment Product Solution and Service
3.5 Date of Enter into Motion Sickness Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Motion Sickness Treatment Historic Market Size by Type (2015-2020)
4.2 Global Motion Sickness Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Motion Sickness Treatment Market Size by Application (2015-2020)
5.2 Global Motion Sickness Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Motion Sickness Treatment Market Size (2015-2020)
6.2 Motion Sickness Treatment Key Players in North America (2019-2020)
6.3 North America Motion Sickness Treatment Market Size by Type (2015-2020)
6.4 North America Motion Sickness Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Motion Sickness Treatment Market Size (2015-2020)
7.2 Motion Sickness Treatment Key Players in Europe (2019-2020)
7.3 Europe Motion Sickness Treatment Market Size by Type (2015-2020)
7.4 Europe Motion Sickness Treatment Market Size by Application (2015-2020)
8 China
8.1 China Motion Sickness Treatment Market Size (2015-2020)
8.2 Motion Sickness Treatment Key Players in China (2019-2020)
8.3 China Motion Sickness Treatment Market Size by Type (2015-2020)
8.4 China Motion Sickness Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Motion Sickness Treatment Market Size (2015-2020)
9.2 Motion Sickness Treatment Key Players in Japan (2019-2020)
9.3 Japan Motion Sickness Treatment Market Size by Type (2015-2020)
9.4 Japan Motion Sickness Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Motion Sickness Treatment Market Size (2015-2020)
10.2 Motion Sickness Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Motion Sickness Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Motion Sickness Treatment Market Size by Application (2015-2020)
11 India
11.1 India Motion Sickness Treatment Market Size (2015-2020)
11.2 Motion Sickness Treatment Key Players in India (2019-2020)
11.3 India Motion Sickness Treatment Market Size by Type (2015-2020)
11.4 India Motion Sickness Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Motion Sickness Treatment Market Size (2015-2020)
12.2 Motion Sickness Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Motion Sickness Treatment Market Size by Type (2015-2020)
12.4 Central & South America Motion Sickness Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Details
13.1.2 GlaxoSmithKline Business Overview
13.1.3 GlaxoSmithKline Motion Sickness Treatment Introduction
13.1.4 GlaxoSmithKline Revenue in Motion Sickness Treatment Business (2015-2020))
13.1.5 GlaxoSmithKline Recent Development
13.2 Perrigo Company
13.2.1 Perrigo Company Company Details
13.2.2 Perrigo Company Business Overview
13.2.3 Perrigo Company Motion Sickness Treatment Introduction
13.2.4 Perrigo Company Revenue in Motion Sickness Treatment Business (2015-2020)
13.2.5 Perrigo Company Recent Development
13.3 Prestige Brands
13.3.1 Prestige Brands Company Details
13.3.2 Prestige Brands Business Overview
13.3.3 Prestige Brands Motion Sickness Treatment Introduction
13.3.4 Prestige Brands Revenue in Motion Sickness Treatment Business (2015-2020)
13.3.5 Prestige Brands Recent Development
13.4 WellSpring Pharmaceutical Corporation
13.4.1 WellSpring Pharmaceutical Corporation Company Details
13.4.2 WellSpring Pharmaceutical Corporation Business Overview
13.4.3 WellSpring Pharmaceutical Corporation Motion Sickness Treatment Introduction
13.4.4 WellSpring Pharmaceutical Corporation Revenue in Motion Sickness Treatment Business (2015-2020)
13.4.5 WellSpring Pharmaceutical Corporation Recent Development
13.5 Caleb Pharmaceuticals
13.5.1 Caleb Pharmaceuticals Company Details
13.5.2 Caleb Pharmaceuticals Business Overview
13.5.3 Caleb Pharmaceuticals Motion Sickness Treatment Introduction
13.5.4 Caleb Pharmaceuticals Revenue in Motion Sickness Treatment Business (2015-2020)
13.5.5 Caleb Pharmaceuticals Recent Development
13.6 Myungmoon Pharm
13.6.1 Myungmoon Pharm Company Details
13.6.2 Myungmoon Pharm Business Overview
13.6.3 Myungmoon Pharm Motion Sickness Treatment Introduction
13.6.4 Myungmoon Pharm Revenue in Motion Sickness Treatment Business (2015-2020)
13.6.5 Myungmoon Pharm Recent Development
13.7 Baxter International
13.7.1 Baxter International Company Details
13.7.2 Baxter International Business Overview
13.7.3 Baxter International Motion Sickness Treatment Introduction
13.7.4 Baxter International Revenue in Motion Sickness Treatment Business (2015-2020)
13.7.5 Baxter International Recent Development
13.8 Reliefband Technologies
13.8.1 Reliefband Technologies Company Details
13.8.2 Reliefband Technologies Business Overview
13.8.3 Reliefband Technologies Motion Sickness Treatment Introduction
13.8.4 Reliefband Technologies Revenue in Motion Sickness Treatment Business (2015-2020)
13.8.5 Reliefband Technologies Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Motion Sickness Treatment Revenue
1.4 Market by Type
1.4.1 Global Motion Sickness Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Anticholinergic
1.4.3 Antihistamines
1.4.4 Others
1.5 Market by Application
1.5.1 Global Motion Sickness Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Motion Sickness Treatment Market Perspective (2015-2026)
2.2 Global Motion Sickness Treatment Growth Trends by Regions
2.2.1 Motion Sickness Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Motion Sickness Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Motion Sickness Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Motion Sickness Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Motion Sickness Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Motion Sickness Treatment Players by Market Size
3.1.1 Global Top Motion Sickness Treatment Players by Revenue (2015-2020)
3.1.2 Global Motion Sickness Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Motion Sickness Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Motion Sickness Treatment Market Concentration Ratio
3.2.1 Global Motion Sickness Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Motion Sickness Treatment Revenue in 2019
3.3 Motion Sickness Treatment Key Players Head office and Area Served
3.4 Key Players Motion Sickness Treatment Product Solution and Service
3.5 Date of Enter into Motion Sickness Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Motion Sickness Treatment Historic Market Size by Type (2015-2020)
4.2 Global Motion Sickness Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Motion Sickness Treatment Market Size by Application (2015-2020)
5.2 Global Motion Sickness Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Motion Sickness Treatment Market Size (2015-2020)
6.2 Motion Sickness Treatment Key Players in North America (2019-2020)
6.3 North America Motion Sickness Treatment Market Size by Type (2015-2020)
6.4 North America Motion Sickness Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Motion Sickness Treatment Market Size (2015-2020)
7.2 Motion Sickness Treatment Key Players in Europe (2019-2020)
7.3 Europe Motion Sickness Treatment Market Size by Type (2015-2020)
7.4 Europe Motion Sickness Treatment Market Size by Application (2015-2020)
8 China
8.1 China Motion Sickness Treatment Market Size (2015-2020)
8.2 Motion Sickness Treatment Key Players in China (2019-2020)
8.3 China Motion Sickness Treatment Market Size by Type (2015-2020)
8.4 China Motion Sickness Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Motion Sickness Treatment Market Size (2015-2020)
9.2 Motion Sickness Treatment Key Players in Japan (2019-2020)
9.3 Japan Motion Sickness Treatment Market Size by Type (2015-2020)
9.4 Japan Motion Sickness Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Motion Sickness Treatment Market Size (2015-2020)
10.2 Motion Sickness Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Motion Sickness Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Motion Sickness Treatment Market Size by Application (2015-2020)
11 India
11.1 India Motion Sickness Treatment Market Size (2015-2020)
11.2 Motion Sickness Treatment Key Players in India (2019-2020)
11.3 India Motion Sickness Treatment Market Size by Type (2015-2020)
11.4 India Motion Sickness Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Motion Sickness Treatment Market Size (2015-2020)
12.2 Motion Sickness Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Motion Sickness Treatment Market Size by Type (2015-2020)
12.4 Central & South America Motion Sickness Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Details
13.1.2 GlaxoSmithKline Business Overview
13.1.3 GlaxoSmithKline Motion Sickness Treatment Introduction
13.1.4 GlaxoSmithKline Revenue in Motion Sickness Treatment Business (2015-2020))
13.1.5 GlaxoSmithKline Recent Development
13.2 Perrigo Company
13.2.1 Perrigo Company Company Details
13.2.2 Perrigo Company Business Overview
13.2.3 Perrigo Company Motion Sickness Treatment Introduction
13.2.4 Perrigo Company Revenue in Motion Sickness Treatment Business (2015-2020)
13.2.5 Perrigo Company Recent Development
13.3 Prestige Brands
13.3.1 Prestige Brands Company Details
13.3.2 Prestige Brands Business Overview
13.3.3 Prestige Brands Motion Sickness Treatment Introduction
13.3.4 Prestige Brands Revenue in Motion Sickness Treatment Business (2015-2020)
13.3.5 Prestige Brands Recent Development
13.4 WellSpring Pharmaceutical Corporation
13.4.1 WellSpring Pharmaceutical Corporation Company Details
13.4.2 WellSpring Pharmaceutical Corporation Business Overview
13.4.3 WellSpring Pharmaceutical Corporation Motion Sickness Treatment Introduction
13.4.4 WellSpring Pharmaceutical Corporation Revenue in Motion Sickness Treatment Business (2015-2020)
13.4.5 WellSpring Pharmaceutical Corporation Recent Development
13.5 Caleb Pharmaceuticals
13.5.1 Caleb Pharmaceuticals Company Details
13.5.2 Caleb Pharmaceuticals Business Overview
13.5.3 Caleb Pharmaceuticals Motion Sickness Treatment Introduction
13.5.4 Caleb Pharmaceuticals Revenue in Motion Sickness Treatment Business (2015-2020)
13.5.5 Caleb Pharmaceuticals Recent Development
13.6 Myungmoon Pharm
13.6.1 Myungmoon Pharm Company Details
13.6.2 Myungmoon Pharm Business Overview
13.6.3 Myungmoon Pharm Motion Sickness Treatment Introduction
13.6.4 Myungmoon Pharm Revenue in Motion Sickness Treatment Business (2015-2020)
13.6.5 Myungmoon Pharm Recent Development
13.7 Baxter International
13.7.1 Baxter International Company Details
13.7.2 Baxter International Business Overview
13.7.3 Baxter International Motion Sickness Treatment Introduction
13.7.4 Baxter International Revenue in Motion Sickness Treatment Business (2015-2020)
13.7.5 Baxter International Recent Development
13.8 Reliefband Technologies
13.8.1 Reliefband Technologies Company Details
13.8.2 Reliefband Technologies Business Overview
13.8.3 Reliefband Technologies Motion Sickness Treatment Introduction
13.8.4 Reliefband Technologies Revenue in Motion Sickness Treatment Business (2015-2020)
13.8.5 Reliefband Technologies Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
